|
Sciele Pharma, Inc. ... ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, has completed its European Phase III study of PSD502 for the...
|
www.medicalnewstoday.com/articles/123777.php
|
|
|
|
Sciele Pharma, Inc. ... ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, and Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, jointly announced that they have initiated patient enrollment for the Phase III...
|
www.medicalnewstoday.com/articles/87459.php
|
|
|
Get Plethora Solutions Holdings PLC (PLE) stock research & investing information. Find historical stock quotes, key competitors, stock data, executive management and the latest company news. ... Snapshot of Plethora Solutions Holdings PLC (PLE)
|
investing.businessweek.com/research/stocks/snapshot/sna...
investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ric=PLE.L
|
|
Plethora Solutions soared 8½p to 24p after the healthcare group announced positive phase III trials results for its treatment for premature ejaculation. Finncap estimates the European and US markets for the product could be worth over $1 billion and notes the group also has cash milestone payments to come from a US deal.
|
business.timesonline.co.uk/tol/business/markets/article...
business.timesonline.co.uk/tol/business/markets/article5110719.ece
|
|
AIM listed, Plethora Solutions has signed an exclusive license to manufacture and market in North America Invicorp, Senetek's plc's patented combination drug treatment for male erectile dysfunction.
|
www.smallcapnews.co.uk/article/Plethora_Solutions_to_ma...
www.smallcapnews.co.uk/article/Plethora_Solutions_to_market_erectile_dysfunction_/1088.aspx
|
|
Plethora Solutions Holdings PLE company news, announcements, releases, reports results & notices ... Latest Plethora Solutions Holdings News Headlines...
|
www.advfn.com/company-news-LSE/Plethora-PLE.html
www.advfn.com/company-news-LSE/Plethora-PLE.html
|
|
PLE Plethora Solutions Clinical Update - PSD502 (Plethora Solutions) ... RNS Number:2223K Plethora Solutions Holdings PLC 19 December 2007 PLETHORA SOLUTIONS HOLDINGS PLC Clinical Update - PSD502 for Premature Ejaculation PSD502 - European Phase III underway Plethora Solutions Holdings PLC ("Plethora", AIM : PLE),
|
www.advfn.com/news_Clinical-Update-PSD502_23845775.html
|
|
Sciele Pharma Inc., a Shionogi Company, and Plethora Solutions Holdings PLC (Plethora - AIM:PLE), announced that a second and final Phase III double-blind, placebo-controlled study of PSD502 for ... Sciele Pharma Inc., a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE), announced that a second...
|
www.medicalnewstoday.com/articles/159381.php
|
|
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation 7/29/2009 9:44:44 AM More...
|
www.biospace.com/company_profile.aspx?CompanyId=926520
|
|
